These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 22453057)

  • 61. Efficacy and effectiveness of artemether-lumefantrine after initial and repeated treatment in children <5 years of age with acute uncomplicated Plasmodium falciparum malaria in rural Tanzania: a randomized trial.
    Ngasala BE; Malmberg M; Carlsson AM; Ferreira PE; Petzold MG; Blessborn D; Bergqvist Y; Gil JP; Premji Z; Björkman A; Mårtensson A
    Clin Infect Dis; 2011 Apr; 52(7):873-82. PubMed ID: 21427394
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Safety and efficacy of lumefantrine-artemether (Coartem) for the treatment of uncomplicated Plasmodium falciparum malaria in Zambian adults.
    Mulenga M; VangGeertruyden JP; Mwananyanda L; Chalwe V; Moerman F; Chilengi R; Van Overmeir C; Dujardin JC; D'Alessandro U
    Malar J; 2006 Aug; 5():73. PubMed ID: 16923176
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Pyronaridine-artesunate or dihydroartemisinin-piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial.
    West African Network for Clinical Trials of Antimalarial Drugs (WANECAM)
    Lancet; 2018 Apr; 391(10128):1378-1390. PubMed ID: 29606364
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Efficacy of fixed-dose combination artesunate-amodiaquine versus artemether-lumefantrine for uncomplicated childhood Plasmodium falciparum malaria in Democratic Republic of Congo: a randomized non-inferiority trial.
    Espié E; Lima A; Atua B; Dhorda M; Flévaud L; Sompwe EM; Palma Urrutia PP; Guerin PJ
    Malar J; 2012 May; 11():174. PubMed ID: 22631564
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Efficacy and tolerability of four antimalarial combinations in the treatment of uncomplicated Plasmodium falciparum malaria in Senegal.
    Faye B; Ndiaye JL; Ndiaye D; Dieng Y; Faye O; Gaye O
    Malar J; 2007 Jun; 6():80. PubMed ID: 17570848
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Haemolytic crisis of blackwater fever following artemether-lumefantrine intake].
    Aloni NM; Nsangu M; Kunuanunua T; Kadima TB; Muanda TF
    Bull Soc Pathol Exot; 2010 Dec; 103(5):296-8. PubMed ID: 20658275
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Coartemether (artemether and lumefantrine): an oral antimalarial drug.
    Wernsdorfer WH
    Expert Rev Anti Infect Ther; 2004 Apr; 2(2):181-96. PubMed ID: 15482185
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Good efficacy of artemether-lumefantrine for uncomplicated falciparum malaria in eastern Sumba, East Nusatenggara, Indonesia.
    Sutanto I; Suprianto S; Widiaty A; Rukmiyati ; Ruckert P; von Bethmann A; de Monbrison F; Picot S; Laihad F; Baird JK
    Acta Med Indones; 2012 Jul; 44(3):187-92. PubMed ID: 22983072
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Artemisinin derivatives and malaria: useful, in combination with other antimalarials.
    Prescrire Int; 2008 Aug; 17(96):162-8. PubMed ID: 19492494
    [TBL] [Abstract][Full Text] [Related]  

  • 70. In vivo/ex vivo efficacy of artemether-lumefantrine and artesunate-amodiaquine as first-line treatment for uncomplicated falciparum malaria in children: an open label randomized controlled trial in Burkina Faso.
    Lingani M; Bonkian LN; Yerbanga I; Kazienga A; Valéa I; Sorgho H; Ouédraogo JB; Mens PF; Schallig HDFH; Ravinetto R; d'Alessandro U; Tinto H
    Malar J; 2020 Jan; 19(1):8. PubMed ID: 31906948
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Suspected allergy to artemether-lumefantrine treatment of malaria.
    Krippner R; Staples J
    J Travel Med; 2003; 10(5):303-5. PubMed ID: 14531988
    [No Abstract]   [Full Text] [Related]  

  • 72. Community-led Responses for Elimination (CoRE): a study protocol for a community randomized controlled trial assessing the effectiveness of community-level, reactive focal drug administration for reducing Plasmodium falciparum infection prevalence and incidence in Southern Province, Zambia.
    Bridges DJ; Miller JM; Chalwe V; Moonga H; Hamainza B; Steketee R; Silumbe K; Nyangu J; Larsen DA
    Trials; 2017 Nov; 18(1):511. PubMed ID: 29096671
    [TBL] [Abstract][Full Text] [Related]  

  • 73. In vivo efficacy of artemether-lumefantrine and artesunate-amodiaquine for uncomplicated Plasmodium falciparum malaria in Malawi, 2014.
    Paczkowski M; Mwandama D; Marthey D; Luka M; Makuta G; Sande J; Ali D; Troell P; Mathanga DP; Gutman J
    Malar J; 2016 Apr; 15():236. PubMed ID: 27113085
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Impact of treatment and re-treatment with artemether-lumefantrine and artesunate-amodiaquine on selection of Plasmodium falciparum multidrug resistance gene-1 polymorphisms in the Democratic Republic of Congo and Uganda.
    Baraka V; Mavoko HM; Nabasumba C; Francis F; Lutumba P; Alifrangis M; Van Geertruyden JP
    PLoS One; 2018; 13(2):e0191922. PubMed ID: 29390014
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Efficacy and safety of artemether-lumefantrine in the treatment of acute, uncomplicated Plasmodium falciparum malaria: a pooled analysis.
    Makanga M; Bassat Q; Falade CO; Premji ZG; Krudsood S; Hunt P; Walter V; Beck HP; Marrast AC; Cousin M; Rosenthal PJ
    Am J Trop Med Hyg; 2011 Nov; 85(5):793-804. PubMed ID: 22049029
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Fatal case of delayed-onset haemolytic anaemia after oral artemether-lumefantrine.
    Gustafsson L; James S; Zhang Y; Thozhuthumparambil KP
    BMJ Case Rep; 2021 Nov; 14(11):. PubMed ID: 34799392
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [A randomized clinical trial comparing the effectiveness and tolerability of artemisinine-naphthoquine (Arco®) and artemether-lumefantrine (Coartem®) in the treatment of uncomplicated malaria in Benin].
    Kinde-Gazard D; Ogouyèmi-Hounto A; Capo-Chichi L; Gbaguidi J; Massougbodji A
    Bull Soc Pathol Exot; 2012 Aug; 105(3):208-14. PubMed ID: 22328063
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Adding a single low-dose of primaquine (0.25 mg/kg) to artemether-lumefantrine did not compromise treatment outcome of uncomplicated Plasmodium falciparum malaria in Tanzania: a randomized, single-blinded clinical trial.
    Mwaiswelo R; Ngasala B; Jovel I; Aydin-Schmidt B; Gosling R; Premji Z; Mmbando B; Björkman A; Mårtensson A
    Malar J; 2016 Aug; 15(1):435. PubMed ID: 27565897
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A randomized trial of artesunate-sulfamethoxypyrazine-pyrimethamine versus artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Mali.
    Sagara I; Dicko A; Djimde A; Guindo O; Kone M; Tolo Y; Thera MA; Sogoba M; Fofana M; Ouattara A; Sissoko M; Jansen HF; Doumbo OK
    Am J Trop Med Hyg; 2006 Oct; 75(4):630-6. PubMed ID: 17038684
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Artemether-lumefantrine for uncomplicated malaria: a systematic review.
    Omari AA; Gamble C; Garner P
    Trop Med Int Health; 2004 Feb; 9(2):192-9. PubMed ID: 15040555
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.